Web26 jan. 2024 · Among last year’s approvals were 31 new therapies for rare diseases. These new medicines include treatments for devastating neurodegenerative diseases such as spinal muscular atrophy and Duchenne muscular dystrophy, dangerous inflammatory conditions such as hereditary angioedema, and several rare and deadly forms of cancers. Web12 apr. 2024 · Bipolar disorders (BDs) are recurrent and sometimes chronic disorders of mood that affect around 2% of the world’s population and encompass a spectrum between severe elevated and excitable mood states (mania) to the dysphoria, low energy, and despondency of depressive episodes. The illness commonly starts in young adults and is …
CDER drug approvals U.S. 2008-2024 Statista
Web4 apr. 2024 · Ozempic Is About to Be Old News. A “huge explosion” in obesity drugs is on the horizon. All of a sudden, Ozempic is everywhere. The weight-loss drug that it … Web3 jan. 2024 · Several notable new drugs are potentially up for approval in 2024, including two amyloid-targeting antibodies for Alzheimer disease, two respiratory syncytial … healthy benefits anthem blue cross
New drug approvals in oncology - PubMed
Web14 apr. 2024 · April 14, 2024. Drugs Regulatory Affairs. CDER’s Office of New Drugs (OND) Director Peter Stein is a nationally recognized leader in pharmaceutical research and development. Before joining the FDA in 2016 as OND deputy director he was a vice president at Merck Research Laboratories and formerly a vice president at Janssen. WebIn 2024, 37 novel drugs were approved by the Center for Drug Evaluation and Research (CDER). The number of new medicinal products entering the pharmaceutical market each year varies... Web14 aug. 2024 · FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis Pretomanid, developed by the non-profit TB Alliance, has received U.S. approval in combination regimen with bedaquiline and linezolid for people with XDR-TB or treatment-intolerant/non-responsive MDR-TB August 14, 2024 healthy benefits anthem otc catalog